参考文献/References:
[1] Siegel R,Naisnadham D,Jemal A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.
[2] 陈武飞,刘海泉,滑炎卿.乳腺癌影像学诊断研究进展[J].中华临床医师杂志:电子版,2013,7(11):123-125.
[3] 刘芳,唐光才.乳腺癌影像诊断的研究现状[J].国际医学放射学杂志,2013,36(6):533-537.
[4] 李丽艳,周顺科,孙划.乳腺癌影像学诊断新进展[J].中国临床研究,2013,26(7):724-725.
[5] Thomassin-Naggara I,De Bazelaire C,Chopier J,et al.Dinusion-weighted MR imaging of the breast:advantages and pitfalls[J].Eur J Radiol,2013,82(3):435-443.
[6] Magometschnigg HF,Helbich T,Brader P,et al.Molecular imaging for the characterization of breast tumors[J].Expert Rev Anticancer Ther,2014,14(6):711-722.
[7] Pinker K,Bogner W,Baltzer P,et al.Clinical application of bilat-eral high temporal and spatial resolution dynamic contrast-en-hanced magnetic resonance imaging of the breast at 7 T[J].Eur Ra-diol,2014,24(4):913-920.
[8] Bains LJ,Zweifel M,Thoeny HC.Therapy response with diffusion MRI:an update[J].Cancer Imaging,2012,12(2):395-402.
[9] 邓丹琼,涂蓉,尤小光,等.磁共振扩散加权成像ADC值与乳腺癌病理组织分级的相关性研究[J].临床放射学杂志,2013,32(10):1428-1431.
[10] Baltzer PA,Dietzel M.Breast lesions:diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T-systematic review and meta-analysis[J].Radiology,2013,267(3):735-746.
[11] Pinker K,Helbich TH,Magometschnigg H,et al.Molekulare Brustbildgebung.Ein Update[J].Radiologe,2014,54(3):241-253.
[12] Pinker K,Bickel H,Helbich TH,et al.Combined contrast-en-hanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions[J].Eur Radiol,2013,23(7):1791-1802.
[13] Fowler AM.A molecular approach to breast imaging[J].J Nucl Med,2014,55(2):177-180.
[14] Bensch F,Kruchten M,Lamberts L,et al.Molecular imaging for monitoring treatment response in breast cancer patients[J].Eur J Pharmacol,2013,717(1-3):2-11.
[15] Kenny LM,Al-Nahhas A,Aboagye EO.Novel PET biomarkers for breast cancer imaging[J].Nucl Med Commun,2011,32(5):333-335.
[16] 黄婷婷,王红亮,唐刚华.细胞凋亡小分子PET显像剂的研究进展[J].同位素,2011,24(4):240-245.
[17] Cheng J,Lei L,Xu J,et al.18F-fluoromisonidazole PET/CT:a po-tential tool for predicting primary endocrine therapy resistance in breast cancer[J].J Nucl Med,2013,54(3):333-340.
[18] van Kruchten M,de Vries EC,Brown M,et al.PET imaging of oe-strogen receptors in patients with breast cancer[J].Lancet Oncol,2013,14(11):e465-e475.
[19] Gemignani1 ML,Patil S,Seshan VE,et al.Feasibility and pre-dictability of perioperative PET and estrogen receptor ligand in pa-tients with invasive breast cancer[J].J Nucl Med,2013,54(10):1697-1702.
[20] Caykema SB,Brouwers AH,Hovenga S,et al.Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clini-cal dilemma in a patient with breast cancer[J].J Clin Oncol,2012,30(6):e74-e75.
[21] Verma S,Miles D,Gianni L,et al.Trastuzumab emtansine for HER2-positivve advanced breast cancer[J].N Engl J Med,2012,367(19):1783-1791.
[22] Tamura K,Kurihara H,Yonemori K,et al.64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer[J].J Nucl Med,2013,54(11):1869-1875.
[23] Smith-Jones PM,Solit DB,Akhurst T,et al.Imaging the pharmaco-dynamics of HER2 degradation in response to Hsp90 inhibitors[J].Nat Biotechnol,2004,22(6):701-706.
[24] 胡鸿,唐刚华,胡孔珍.肿瘤酸性pH分子显像研究进展[J].同位素,2014,27(3):179-187.
[25] 董佳佳,章斌.多种影像学方法评价乳腺癌新補助化疗疗效的价值比较[J].国际放射医学核医学杂志,2014,38(6):427-432.
相似文献/References:
[1]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[2]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[3]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[4]李敏,蒋涛,彭朋,等.直肠内注入模拟粪便的动态MRI对女性盆底痉挛综合征的诊断价值[J].国际放射医学核医学杂志,2016,40(3):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
Li Min,Jiang Tao,Peng Peng,et al.Value of dynamic MRI with rectum injection in the diagnosis of female spastic pelvic floor syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
[5]唐令胜,刘朝晖,李红梅,等.低场磁共振DWI技术与常规MRI扫描对超急性脑梗死的诊断灵敏度的比较[J].国际放射医学核医学杂志,2016,40(3):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
Tang Lingsheng,Liu Zhaohui,Li Hongmei,et al.Comparison of the diagnostic sensitivity of low-field magnetic resonance diffusion weighted imaging technology and conventional MRI scanning for super acute cerebral infarction[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
[6]贺小红,周新韩,高明勇,等.模型模拟修改部分扫描参数加速MR扫描的方法可行性探讨[J].国际放射医学核医学杂志,2016,40(4):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
He Xiaohong,Zhou Xinhan,Gao Mingyong,et al.Feasibility of accelerating MR scan by modifying part of scanning parameters：a phantom simulation study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
[7]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[8]卢瑞梁,贺小红,蔡华清,等.不同MRI序列检出聚丙烯酰胺水凝胶注射隆乳患者乳腺病变效能的比较研究[J].国际放射医学核医学杂志,2016,40(6):435.[doi:10.3760/cma.j.issn.1673-4114.2016.06.007]
Lu Ruiliang,He Xiaohong,Cai Huaqing,et al.The different MRI sequences to detect breast lesions in polyacrylamide hydrogel injection for augmentation patients: a comparative study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):435.[doi:10.3760/cma.j.issn.1673-4114.2016.06.007]
[9]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[10]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[11]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[12]董佳佳,章斌.多种影像学方法评价乳腺癌新辅助化疗疗效的价值比较[J].国际放射医学核医学杂志,2014,38(6):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
Dong Jia-jia,Zhang Bin.Comparision on the values of different image modalities in monitoring the response to neoadjuvant chemotherapy in breast cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
[13]袁建伟,杨劼,贺小红,等.乳腺癌18F-FDG PET/CT和3.0T MRI联合显像评分与Ki-67表达水平的相关性分析[J].国际放射医学核医学杂志,2013,37(2):84.[doi:10.3760/cma.j.issn.1673-4114.2013.02.006]
YUAN Jian-wei,YANG Jie,HE Xiao-hong,et al.Correlation between combined imaging modalities of 18F-FDG PET/CT and 3.0T MRI and expression of Ki-67 in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):84.[doi:10.3760/cma.j.issn.1673-4114.2013.02.006]
[14]袁建伟,杨劼,贺小红,等.18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值[J].国际放射医学核医学杂志,2013,37(4):199.[doi:10.3760/cma.j.issn.1673-4114.2013.04.003]
YUAN Jian-wei,YANG Jie,HE Xiao-hong,et al.Diagnosis value of 18F-FDG PET/CT and 3.0T MRI combined imaging in detecting the primary focus of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):199.[doi:10.3760/cma.j.issn.1673-4114.2013.04.003]
[15]夏晓天,张永学.影像学检查在乳腺癌的诊断及疗效评估中的应用价值[J].国际放射医学核医学杂志,2010,34(4):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]
XIA Xiao-tian,ZHANG Yong-xue.The value of imaging examinations in diagnosis and curative effect evaluation of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]
[16]郭慧敏,赵晋华.应用影像学方法评价乳腺癌新辅助化疗疗效[J].国际放射医学核医学杂志,2009,33(3):149.[doi:10.3760/cma.j.issn.1673-4114.2009.03.006]
GUO Hui-min,ZHAO Jin-hua.Imaging evaluation of breast cancer treated with neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(1):149.[doi:10.3760/cma.j.issn.1673-4114.2009.03.006]
[17]赵晋华,郭慧敏.综合应用临床影像学对乳腺癌进行筛查、诊断和分期[J].国际放射医学核医学杂志,2009,33(4):222.[doi:10.3760/cma.j.issn.1673-4114.2009.04.009]
ZHAO Jin-hua,GUO Hui-min.The combination of clinical imaging methods in the screening, diagnosis and staging of patients with breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(1):222.[doi:10.3760/cma.j.issn.1673-4114.2009.04.009]